Bladder Scanners Market Size to Reach USD 147 Million by 2031 | Key Trends & Forecasts

 


Global bladder scanners market is entering a new phase of technology-driven growth, fueled by increasing adoption of non-invasive diagnostics, rising urological disease prevalence, and strong investments in connected medical imaging solutions. Valued at USD 88.9 million in 2024, the market is set to climb to USD 147 million by 2031, registering a CAGR of 7.7% and underscoring its expanding clinical and economic relevance across the healthcare ecosystem.

Access the full bladder scanners market report, detailed insights, and expert forecasts at 24LifeSciences: https://www.24lifesciences.com/bladder-scanners-market-8140

Emerging Healthcare Trends Reshaping the Bladder Scanners Market

Rapid advancements in ultrasound imaging, the rise of connected medical devices, and the broader digitalization of hospital workflows are significantly accelerating market momentum. In 2025 and beyond, hospitals are prioritizing AI-assisted imaging, automated bladder volume measurements, and integration with electronic health records, enabling faster assessment and reducing operator variability.

Healthcare systems are increasingly focusing on reducing catheter-associated urinary tract infections (CAUTIs) — a key global patient-safety priority emphasized by leading health authorities such as the World Health Organization (WHO). This shift is driving widespread adoption of non-invasive bladder scanners as a standard diagnostic tool.

The emergence of portable and handheld devices, alongside the rising importance of telehealth-supported point-of-care diagnostics, further positions bladder scanners as essential equipment across both acute and long-term care settings.

 

Key Market Drivers

  • Shift toward non-invasive urological diagnostics
    Bladder scanners significantly reduce the need for catheterization, lowering infection risk and improving patient comfort.
  • Technological evolution toward advanced/connected devices
    Wireless data transfer, AI-assisted analytics, and cloud-based trend tracking support streamlined clinical decision-making.
  • High demand across hospitals and emergency departments
    Rapid bladder volume assessments are vital in post-operative care, urinary retention monitoring, and critical care workflows.
  • Growing geriatric population worldwide
    Rising prevalence of conditions such as benign prostatic hyperplasia (BPH) and neurogenic bladder is creating sustained demand.
  • Healthcare investments in workflow optimization
    Providers increasingly prioritize devices that reduce procedure times, enhance accuracy, and lower long-term costs.

Download the full high-level industry report, market modeling, and strategic insights from 24LifeSciences https://www.24lifesciences.com/download-sample/8140/bladder-scanners-market

Competitive Landscape: Leading Companies Shaping Global Innovation

Major manufacturers are expanding their portfolios with AI-integrated imaging, ergonomic designs, and mobile-friendly platforms. Key companies driving the global bladder scanners market include:

  • Verathon Inc. – A pioneer in 3D bladder scanning technology, enhancing real-time volumetric accuracy and hospital integration.
  • MCube Technology Co., Ltd. – Strengthening its position through portable, lightweight scanners optimized for point-of-care use.
  • Laborie Medical Technologies – Focusing on digital urodynamics and advanced ultrasound innovations.
  • Vitacon – Known for fast-scan handheld systems increasingly used in emergency and critical care.
  • Caresono Technology Co., Ltd. – Expanding access across Asia-Pacific with cost-effective scanner solutions.

With rising competition, companies are prioritizing R&D investment, global distribution partnerships, ergonomic usability, and connected health capabilities.

 

Segment Insights & Regional Overview

By Type

  • 3D Ultrasound Bladder Scanners dominate the market, offering superior volumetric accuracy, enhanced clinical confidence, and greater ease of use.
  • 2D scanners remain relevant but are rapidly being replaced in settings where precision is critical.

By Application

  • Hospitals lead globally, driven by high patient volumes, surgical monitoring requirements, and infection-control protocols.
  • Clinics and homecare settings are showing rising adoption due to portable device innovations.

By End User

  • Urology Departments represent the most significant demand center, given the essential role of bladder scanners in urodynamic evaluation and post-void residual assessment.
  • Emergency & Critical Care units rely on rapid, non-invasive diagnostics for acute urinary retention.

By Technology Level

  • Advanced/Connected Scanners are the fastest-growing segment, driven by EHR integration, cloud analytics, and wireless mobility.
  • Handheld portable devices support decentralized diagnostics in homecare and remote facilities.

By Purchasing Model

  • Capital Equipment Purchase remains dominant, especially among large hospitals.
  • Flexibility-driven Rental/Lease and Pay-Per-Use models are gaining traction among smaller clinics.

Get the full report with actionable insights, pricing analysis, and technology review at 24LifeScienceshttps://www.24lifesciences.com/bladder-scanners-market-8140

 

Regional Market Dynamics

North America

North America leads the market, driven by high healthcare expenditure, strong clinical adoption, and regulatory emphasis on diagnostic accuracy. The U.S. remains the core revenue hub, strengthened by high prevalence of urological disorders and rapid integration of connected medical technologies.

Europe

A mature and highly regulated market, Europe exhibits strong adoption in Germany, the UK, France, and the Nordics. Government initiatives supporting non-invasive diagnostics and aging demographics continue to fuel demand.

Asia-Pacific

The fastest-growing region, supported by expanding healthcare infrastructure, rising medical tourism, and increasing awareness of CAUTI prevention. China, India, Japan, and South Korea are significant contributors.

South America

Growth remains developing, with Brazil leading adoption in private hospitals. Budget constraints temper expansion but rising CAUTI awareness is gradually driving procurement.

Middle East & Africa

Fragmented but growing, with GCC nations exhibiting high adoption and African markets showing gradual progress tied to healthcare modernization.

 

Can AI-Driven Care Models Reshape the Future of Urological Diagnostics?

AI-powered imaging analysis, automated bladder volume calculations, and predictive analytics are transforming how clinicians assess urinary function. As hospitals adopt next-generation connected scanners, the industry is moving toward precision diagnostics, reduced operator dependency, and data-driven patient management—defining the future of urological care.

 

Key Benefits of the Report

  • Comprehensive segmentation across type, application, end user, technology level, and purchasing model
  • Seven-year forecast with detailed CAGR analysis
  • Competitive benchmarking of leading global manufacturers
  • Identification of emerging clinical and technological opportunities
  • Strategic guidance for investors, innovators, and healthcare policymakers

Review the complete market forecast, segmentation insights, and growth strategy framework at 24LifeSciences https://www.24lifesciences.com/bladder-scanners-market-8140

 

Future Perspective

As global healthcare systems continue shifting toward patient safety, precision diagnostics, and digital interoperability, the bladder scanners market stands at the forefront of non-invasive diagnostic innovation. Stakeholders prepared to leverage connected technologies and expand into high-growth regions will benefit most from the market’s accelerating trajectory through 2031.

 

About 24lifesciences

Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market

International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)

Website: http://www.24lifesciences.com                                          

Follow us on LinkedIn: http://www.linkedin.com/company/lifesciences24

Comments

Post a Comment

Popular posts from this blog

Mechanical Rubber Tracks Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2031

Mechanical rubber tracks, also referred to as rubber track pads or rubber belting, are robust traction surfaces used on heavy equipment and vehicles. These tracks are manufactured using high-strength rubber compounds designed to deliver optimal traction and support on various terrains, including soft soil, mud, snow, and ice. They are often utilized as a substitute for traditional steel tracks on equipment such as bulldozers, excavators, and military vehicles. Mechanical rubber tracks provide numerous advantages, including reduced ground pressure, enhanced mobility, and quieter operations compared to steel tracks. Get free sample of this report at :  https://www.intelmarketresearch.com/download-free-sample/529/mechanical-rubber-tracks-market  Market Size In 2024, the global market for Mechanical Rubber Tracks was valued at USD 2,163.82 million, reflecting significant growth from USD 1,541.86 million in 2020. The market is projected to grow at a compound annual growth rate (CAG...
Read more

Nitrogen Localized Cryotherapy Machine Market Forecast 2026: Revenue Insights

Image
  According to a newly published market research report by 24LifeSciences , the global nitrogen localized cryotherapy machine market was valued at USD 102.4 million in 2024  and is projected to reach USD 185.6 million by 2032 , growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025–2032 . Nitrogen localized cryotherapy machines represent advanced medical and wellness devices engineered for the highly precise application of extremely cold liquid nitrogen vapor to targeted body areas. This non-invasive therapeutic approach induces rapid localized vasoconstriction followed by vasodilation, effectively reducing inflammation, alleviating pain, and accelerating muscle recovery through enhanced blood flow to treated tissues. Distinct from whole-body cryotherapy systems, these devices focus treatment specifically on injury sites or aesthetic zones, providing practitioners with unparalleled control and patients with targeted therapeutic benefits. Down...
Read more

2-Methoxyestradiol Reagent Market to Reach USD 10.8 Billion by 2032 | CAGR 10.8%

Image
  According to a newly published market research report by 24LifeSciences , global 2-Methoxyestradiol Reagent market was valued at USD 113 million in 2024  and is projected to reach USD 232 million by 2031 , growing at a compound annual growth rate (CAGR) of 10.8% during the forecast period 20252031 . 2-Methoxyestradiol, a naturally occurring metabolite of estradiol, has gained significant importance in biomedical research due to its demonstrated anti-cancer properties and unique mechanism of action. As an endogenous compound that inhibits microtubule assembly and demonstrates anti-angiogenic effects, this reagent has become indispensable for researchers studying cancer therapeutics, cellular pathways, and drug development processes. Its established role in disrupting cancer cell proliferation continues to underpin its critical position in modern molecular biology and pharmaceutical research. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-...
Read more